DENVER, CO — RxAssurance Corporation, developer of the OpiSafe™ and RxAdvisor™ medication management solutions, has expanded into Pennsylvania through a new Innovation Partnership with Gateway Recovery Center (GRC).
Gateway went live with OpiSafe on April 1, 2026, using the platform to support safer opioid and other controlled-substance prescribing, monitoring, and medication management. As an RxAssurance Innovation Partner, Gateway will work closely with the company as it expands use of the platform’s capabilities over the coming year.
The partnership represents an important step in RxAssurance’s growing emphasis on behavioral health medication management, where clinical decision support, risk identification, patient engagement, and treatment navigation can be brought together within a coordinated technology platform.
“Gateway is an important partner for us as we expand into Pennsylvania and continue building our presence in behavioral health,” said Robert J. Valuck, PhD, RPh, FNAP, Co-Founder and CEO of RxAssurance. “Their organization provides an excellent environment for demonstrating the breadth of our capabilities, and we look forward to working together as they expand their use of the platform.”
The Pennsylvania launch marks another step in RxAssurance’s continued expansion of the RxAdvisor™ Medication Management Platform into new healthcare markets and clinical settings.